Treatment of <i>JAK2</i> V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report. [PDF]
Zhu F, Wang H, Qiu L.
europepmc +1 more source
18F-FDG PET/CT findings in a mucosa-associated lymphoid tissue lymphoma patient coexisting with primary myelofibrosis. [PDF]
Han Y, Wu R, Zhang Y, Zhang X, Gao Z.
europepmc +1 more source
Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis. [PDF]
Visani G+8 more
europepmc +1 more source
CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis. [PDF]
Vermeersch G+4 more
europepmc +1 more source
Easily Applicable Predictive Score for Differential Diagnosis of Prefibrotic Primary Myelofibrosis from Essential Thrombocythemia. [PDF]
Lekovic D+8 more
europepmc +1 more source
RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis. [PDF]
Han L+4 more
europepmc +1 more source
Case report: Successful use of ruxolitinib to treat interstitial pneumonia as an unusual primary presentation in primary myelofibrosis-two birds with one stone. [PDF]
Xiao P+5 more
europepmc +1 more source
How I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 2024. [PDF]
Griesshammer M+10 more
europepmc +1 more source
Case report: Primary myelofibrosis presenting with portal hypertension mimicking cirrhosis. [PDF]
Gan X+7 more
europepmc +1 more source
Primary myelofibrosis in rheumatic diseases
Vladimir Ivanovich Vasilyev+8 more
doaj +1 more source